期刊文献+

精子蛋白17作为妇科肿瘤诊治靶标的实验研究 被引量:2

暂未订购
导出
作者 李芳秋
出处 《医学研究生学报》 CAS 2010年第9期897-899,共3页 Journal of Medical Postgraduates
基金 国家自然科学基金(30670599) 国家973计划项目基金(2006CB705707) 南京军区医学科学技术"十一五"计划重点项目基金(06Z43)
  • 相关文献

参考文献29

  • 1Simpson AJ,Caballero OL,Jungbluth A,et al.Cancer/testis antigens,gametogenesis and cancer[J].Nat Rev Cancer,2005,5(8):615-625.
  • 2Chen YT.Cancer vaccine:Identification of human tumor antigen by SEREX[J].Cancer J Sci Am,2000,6 (Suppl 3):208-217.
  • 3O'Rand MG,Widgren EE,Fisher SJ.Characterization of the rabbit sperm membrance autoantigen,RSA,as a lectin-link zona binding protein[J].Dev Biol,1988,129 (1):231-240.
  • 4Lea IA,Richardson RT,Widgren EE,et al.Cloning and sequencing of cDNAs encoding the human sperm protein,Sp17[J].Biochim Biophys Acta,1996,1307 (3):263-266.
  • 5Richardson RT,Yamasaki N,O'rand MG.Sequence of a rabbit sperm zona pellucida binding protein and localization during the acrosome reacting[J].Dev Biol,1994,165 (2):688-701.
  • 6Lim SH,Wang Z,Chiriva-Internati M,et al.Sperm protein 17 is a novel cancer-testis antigen in multiple myeloma[J].Blood,2001,97 (5):1508-1510.
  • 7Dong G,Lokinova E,Smith CW,et al.Genes differentially expressed with malignant transformation and metastatic tumor progression of murine squamous cell carcinoma[J].J Cell Biochem Suppl,1997,28-29:90-100.
  • 8de Jong A,Buchli R,Robbins D.Characterization of sperm protein 17 in human somatic and neoplastic tissue[J].Cancer Lett,2002,186 (1):201-209.
  • 9Chiriva-Internati M,Wang Z,Xue Y,et al.Sperm protein 17 (Sp17) in multiple myeloma:opportunity for myeloma specific donor T cell infusion to enhance graft versus myeloma effect without increasing graft verus host disease risk[J].Eur J Immunol,2001,31 (8):2277-2283.
  • 10Straughn JMJ,Shaw DR,Guerrero A,et al.Expression of sperm protein 17 (Sp17) in ovarian cancer[J].Int J Cancer,2004,108 (6):805-811.

二级参考文献67

共引文献18

同被引文献38

  • 1李芳秋,刘群.肿瘤诊断与免疫治疗的新靶标精子蛋白17[J].肿瘤防治杂志,2005,12(11):869-872. 被引量:5
  • 2李芳秋,杨爱龙,缪家文,张春华,吴波,张新华.人精子蛋白17单克隆抗体的制备及特性鉴定[J].细胞与分子免疫学杂志,2006,22(5):638-640. 被引量:13
  • 3Kohler N, Fryxell GE, Zhang M. A bifunctional poly(ethylene glycol) silane immobilized on metallic oxide-based nanoparticles for conjugation with cell targeting agents. J Am Chem Soc, 2004, 126(23): 7206~7211.
  • 4Petri-Fink A, Chastellain M, Juillerat-Jeanneret L, Ferrari A, Hofmann H. Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells. Biomaterials, 2005, 26(15): 2685-2694.
  • 5Zhang Y, Kohler N, Zhang M. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials, 2002, 23(7):1553~1561.
  • 6Weissleder R, Moore A, Mahmood U, Bhorade R, Benveniste H, Chiocca EA, Basilion JP. In vivo magnetic resonance imaging of transgene expression. Nat Med, 2000, 6(3): 351~355.
  • 7Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, Weissleder R. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol, 2000, 18(4): 410~414.
  • 8Zhao M, Beauregard DA, Loizou L, Davletov B, Brindle KM. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nat Med, 2001, 7(11): 1241~1244.
  • 9Artemov D, Mori N, Ravi R, Bhujwalla ZM. Magnetic resonance molecular imaging of the HER-2/neu receptor. Cancer Res, 2003, 63(11): 2723~2727.
  • 10Mauro F. Cancer nanotechnology: Opportunities and challenges. Nat Rev, 2005, 5(3): 161~171.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部